Waddell & Reed Financial’s Tandem Diabetes Care TNDM Stock Holding History

Waddell & Reed Financial’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	$82.9M	Buy	939,686 +63,531	+7%	+$5.9M	0.17%	167
2020 Q4	$83.8M	Sell	876,155 -379,846	-30%	-$39.1M	0.18%	160
2020 Q3	$143M	Buy	1,256,001 +492,500	+65%	+$51.7M	0.34%	70
2020 Q2	$75.5M	Buy	763,501 +432,555	+131%	+$34.5M	0.2%	135
2020 Q1	$21.3M	Sell	330,946 -135,238	-29%	-$9.48M	0.07%	274
2019 Q4	$27.8M	Buy	466,184 +297,138	+176%	+$18.3M	0.07%	292
2019 Q3	$9.97M	Sell	169,046 -30,878	-15%	-$1.97M	0.03%	389
2019 Q2	$12.9M	Sell	199,924 -6	-0%	-$387	0.03%	391
2019 Q1	$12.7M	Sell	199,930 -62,863	-24%	-$3.3M	0.03%	409
2018 Q4	$9.98M	Buy	+262,793	New	+$9.28M	0.03%	416

Other funds holding TNDM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Waddell & Reed Financial's TNDM Position: Q1 2021 in Review

Waddell & Reed Financial increased its Tandem Diabetes Care (TNDM) stake by 7.3% in Q1 2021, buying an estimated $5.9M and bringing the position to 939,686 shares worth $82.9M. The position accounts for 0.17% of the portfolio, ranked #167.

Waddell & Reed Financial first reported a position in TNDM in Q4 2018 and has held it in 10 quarters since. The position peaked at $143M in Q3 2020. 290 funds tracked by Wall St. Rank hold TNDM as of Q1 2021.

Waddell & Reed Financial held 939,686 shares of Tandem Diabetes Care worth $82.9M as of Q1 2021.
Waddell & Reed Financial bought 63,531 Tandem Diabetes Care shares in Q1 2021, an estimated $5.9M.
Tandem Diabetes Care made up 0.17% of Waddell & Reed Financial's portfolio in Q1 2021, its #167 holding.
Waddell & Reed Financial first reported a position in Tandem Diabetes Care in Q4 2018 and has held it in 10 quarters since.
Waddell & Reed Financial's Tandem Diabetes Care position peaked at $143M in Q3 2020.
290 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2021.

Based on Waddell & Reed Financial's 13F filing for Q1 2021, filed 12 May 2021.